Bisphosphonates for post-menopausal osteoporosis: are they all the same?

Incidence of Osteonecrosis of the Jaw in Women With Postmenopausal Osteoporosis in the Health Outcomes and Reduced Incidence With Zoledronic Acid Once Yearly Pivotal Fracture Trial

(2014) John T. Grbic et al.   JOURNAL OF THE AMERICAN DENTAL ASSOCIATION

Systematic Review: Comparative Effectiveness of Treatments to Prevent Fractures in Men and Women with Low Bone Density or Osteoporosis

(2013) Catherine MacLean et al.   ANNALS OF INTERNAL MEDICINE

Atypical fractures of the femur and bisphosphonate therapy

(2010) Andrea Giusti et al.   BONE

Review of the cardiovascular safety of zoledronic acid and other bisphosphonates for the treatment of osteoporosis

(2010) A. John Camm   CLINICAL THERAPEUTICS

A comparison of morphometric definitions of vertebral fracture

(2010) Rebecca Smith-Bindman et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Vertebral fracture assessment using a semiquantitative technique

(2010) Harry K. Genant et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Characterization of and Risk Factors for the Acute-Phase Response after Zoledronic Acid

(2010) I. R. Reid et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Effect of Osteoporosis Treatment on Mortality: A Meta-Analysis

(2010) Mark J. Bolland et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Bisphosphonates and Fractures of the Subtrochanteric or Diaphyseal Femur

(2010) Dennis M. Black et al.   NEW ENGLAND JOURNAL OF MEDICINE

Treatment of osteoporosis with annual iv zoledronic acid: effects on hip fracture

(2010) Roland Chapurlat   Therapeutics and Clinical Risk Management

Risk of fracture in women treated with monthly oral ibandronate or weekly bisphosphonates: The eValuation of IBandronate Efficacy (VIBE) database fracture study

(2009) S.T. Harris et al.   BONE

Bone Turnover in Bone Biopsies of Patients with Low-Energy Cortical Fractures Receiving Bisphosphonates: A Case Series

(2009) Reina Armamento-Villareal et al.   CALCIFIED TISSUE INTERNATIONAL

Low-Energy Femoral Fractures Associated with the Long-Term Use of Bisphosphonates

(2009) Kuntheavy Ing-Lorenzini et al.   DRUG SAFETY

Bisphosphonate Associated Osteonecrosis of the Jaw

(2009) A. A. KHAN et al.   JOURNAL OF RHEUMATOLOGY

Adverse Effects of Bisphosphonates: Implications for Osteoporosis Management

(2009) Kurt A. Kennel et al.   MAYO CLINIC PROCEEDINGS

More on Reports of Esophageal Cancer with Oral Bisphosphonate Use

(2009)   NEW ENGLAND JOURNAL OF MEDICINE

Reports of Esophageal Cancer with Oral Bisphosphonate Use

(2009) Diane K. Wysowski   NEW ENGLAND JOURNAL OF MEDICINE

Adherence to weekly oral bisphosphonate therapy: cost of wasted drugs and fractures

(2009) O. Sheehy et al.   OSTEOPOROSIS INTERNATIONAL

Absolute risk reduction in osteoporosis: assessing treatment efficacy by number needed to treat

(2009) Johann D. Ringe et al.   RHEUMATOLOGY INTERNATIONAL

Differences in persistence, safety and efficacy of generic and original branded once weekly bisphosphonates in patients with postmenopausal osteoporosis: 1-year results of a retrospective patient chart review analysis

(2009) Johann D. Ringe et al.   RHEUMATOLOGY INTERNATIONAL

Zoledronic acid for the treatment and prevention of primary and secondary osteoporosis

(2009) René Rizzoli   Therapeutic Advances in Musculoskeletal Disease

Low-Energy Femoral Shaft Fractures Associated With Alendronate Use

(2008) Andrew S Neviaser et al.   JOURNAL OF ORTHOPAEDIC TRAUMA

Renal safety of annual zoledronic acid infusions in osteoporotic postmenopausal women

(2008) Steven Boonen et al.   KIDNEY INTERNATIONAL

Association of low-energy femoral fractures with prolonged bisphosphonate use: a case control study

(2008) B. A. Lenart et al.   OSTEOPOROSIS INTERNATIONAL

European guidance for the diagnosis and management of osteoporosis in postmenopausal women

(2008) J. A. Kanis et al.   OSTEOPOROSIS INTERNATIONAL

Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy

(2008) R. G. G. Russell et al.   OSTEOPOROSIS INTERNATIONAL

Metastatic bone pain: treatment options with an emphasis on bisphosphonates

(2008) Roger von Moos et al.   SUPPORTIVE CARE IN CANCER

Preclinical evidence for nitrogen-containing bisphosphonate inhibition of farnesyl diphosphate (FPP) synthase in the kidney: Implications for renal safety

(2008) Anke Lühe et al.   TOXICOLOGY IN VITRO